Fortrea Holdings Inc.
A global contract research organization that helps pharmaceutical, biotech, and medical device companies run clinical trials, from early safety studies to final-stage testing. Its roots stretch back to Covance and to a clinical business founded in 1968, and in 2023 it was spun off from the lab giant Labcorp to stand on its own. The name "Fortrea" is a made-up word from that split, likely blending "fortitude" and "trial" — a nod to the strength of the clinical studies it runs.
Granted 148.5K
Granted 30.6K · Sold 11.7K
Granted 29.3K · Sold 15.9K
Granted 62.8K
Granted 38.8K
Granted 38.8K
Granted 38.8K
Granted 38.8K
Granted 5.3K · Sold 3.9K
| Insider | Stake change | Holds now | Granted / vested | Bought | Sold |
|---|---|---|---|---|---|
| Neupert Peter MDirector · 1 transaction | +151.4% | 246.7K | 148.5K | — | — |
| Mcconnell Jill G.Chief Financial Officer · 7 transactions | +31.6% | 78.4K | 30.6K | — | 11.7K |
| Morais Mark A.Chief Operating Officer · 8 transactions | +21.2% | 76.0K | 29.3K | — | 15.9K |
| Russell Erin LDirector · 2 transactions | +636.9% | 72.6K | 62.8K | — | — |
| Pesicka Edward ADirector · 1 transaction | +284.7% | 52.5K | 38.8K | — | — |
| Ray AmritDirector · 1 transaction | +284.7% | 52.5K | 38.8K | — | — |
| Smith David RossDirector · 2 transactions | +406.7% | 48.4K | 38.8K | — | — |
| Sanders MachelleDirector · 1 transaction | +533.1% | 46.1K | 38.8K | — | — |
| Parks RobertChief Accounting Officer · 4 transactions | +7.1% | 20.4K | 5.3K | — | 3.9K |
Select a row to see that insider’s individual transactions. Sum of the holdings confirmed in the 12 months before this insider's last filing. A Form 4 reports a holding per line — held directly, or through a named trust, partnership or foundation, and in each share class separately — never a person’s total. Lines not restated in that time are left out and shown apart: an active filer restates what they still hold, so a line they did not restate is more often an entity since renamed, whose shares a successor line reports too. An amber marker means some were left out.
Net open-market activity over the last 6 months: -31.6K shares. Grants, option exercises and tax withholding are excluded — they are compensation mechanics, not decisions to buy or sell.